Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve Un-Audited Financial Results ....
RESULTS
● No Immediate Change
LOW RISK
📅 Filed on BSE: 03 Aug 2026, 03:58 PM IST · BSE ID: 1783568b-4de0-4b23-b8c6-58581cebf6a6
View Original BSE Filing (PDF)
💡
In Simple Terms
Kimia Biosciences will hold a board meeting on August 10, 2026, to review its financial results for April to June 2026.
🤖 AI Summary
- Kimia Biosciences Board of Directors to meet on August 10, 2026.
- Meeting to consider and approve Un-Audited Financial Results for Q1 FY27.
- Results cover the first quarter ended June 30, 2026 (Q1 FY27 Standalone).
- Trading window for designated persons closed from July 1, 2026.
- Window reopens 48 hours post-result declaration to the Stock Exchange.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this intimation of a future board meeting.
👤
Who Is Affected
Shareholders are indirectly affected as future financial results, once declared, will provide an update on the company's performance for the quarter ended June 30, 2026.
🔍
Management Signal
Management is adhering to regulatory requirements by intimating the upcoming Board Meeting for financial result approval and enforcing the trading window closure.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Board Meeting Outcome on August 10, 2026 – formal declaration of Q1 FY27 results.
Release of Un-Audited Financial Results for Q1 FY27 – review performance metrics.
Trading window reopening date – watch for announcement after result declaration.
LOW RISK
The filing is a routine regulatory intimation of a board meeting for financial results, carrying minimal inherent risk.
💡 Investor Takeaway
Kimia Biosciences has scheduled a Board Meeting on August 10, 2026, to consider and approve its Un-Audited Financial Results (Standalone) for the first quarter ended June 30, 2026, as per Regulation 29 of SEBI (LODR) Regulations, 2015.
📅 Company Track Record
Kimia Biosciences reported a Net Profit of Rs. 1,991.70 Lacs for the full fiscal year ended March 31, 2026, as per its filing on June 1, 2026. This upcoming meeting will provide the first quarterly update for FY27.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
When is Kimia Biosciences' Board Meeting scheduled to approve financial results?
Kimia Biosciences' Board Meeting is scheduled for Monday, August 10, 2026, to consider and approve Un-Audited Financial Results.
Which financial period will be considered at the upcoming Kimia Biosciences Board Meeting?
The Board Meeting on August 10, 2026, will consider the Un-Audited Financial Results (Standalone) for the first quarter ended on June 30, 2026.
When did the trading window close for Kimia Biosciences' designated persons?
The trading window for dealing in Kimia Biosciences Equity Shares by Designated Persons closed with effect from July 1, 2026.
When will the trading window reopen for Kimia Biosciences?
The trading window will reopen after the completion of 48 hours following the declaration of the unaudited Financial Results for the 1st quarter ended June 30, 2026, to the Stock Exchange.
Questions based on this BSE filing only. For information purposes.